The role of ALOX15 in inflammation-related diseases

Read full text
Authors: Rong Tang, Chao-yang Gong, Yang Liu, Hai-lian Zhong, Y. F. Wang, Hai-yu Zhou
Cited by: 3
References: 202

Abstract

Arachidonate 15-lipoxygenase (ALOX15) is a key member of the lipoxygenase family, catalyzing the oxidation of polyunsaturated fatty acids (PUFAs) to produce numerous biologically active lipid mediators. Recent studies have revealed that ALOX15 and its metabolites play a complex regulatory role in inflammatory responses. They are not only involved in inflammation resolution through the production of pro-resolving mediators but can also generate pro-inflammatory lipid signals that exacerbate inflammatory damage. Research utilizing gene knockout and transgenic animal models further indicates that ALOX15 contributes to the pathogenesis of various inflammation-related diseases, including neuroinflammation, atherosclerosis, asthma, rheumatoid arthritis, and metabolic inflammatory diseases. This article systematically reviews the current understanding of the role of ALOX15 in inflammation-associated diseases.

Fields of Study & Subjects

Asthma and respiratory diseases Phosphodiesterase function and regulation Fatty Acid Research and Health

Publication details

Journal / source
Frontiers in Immunology
Publisher
Frontiers Media SA
Volume
17
Pages
1790402–1790402
Publication date
2 April 2026
Language
EN